Mapping distribution of brain metastases: does the primary tumor matter?

Standard

Mapping distribution of brain metastases: does the primary tumor matter? / Schroeder, T; Bittrich, P; Kuhne, J F; Noebel, C; Leischner, H; Fiehler, J; Schroeder, J; Schoen, G; Gellißen, S.

In: J NEURO-ONCOL, Vol. 147, No. 1, 03.2020, p. 229-235.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Schroeder, T, Bittrich, P, Kuhne, JF, Noebel, C, Leischner, H, Fiehler, J, Schroeder, J, Schoen, G & Gellißen, S 2020, 'Mapping distribution of brain metastases: does the primary tumor matter?', J NEURO-ONCOL, vol. 147, no. 1, pp. 229-235. https://doi.org/10.1007/s11060-020-03419-6

APA

Schroeder, T., Bittrich, P., Kuhne, J. F., Noebel, C., Leischner, H., Fiehler, J., Schroeder, J., Schoen, G., & Gellißen, S. (2020). Mapping distribution of brain metastases: does the primary tumor matter? J NEURO-ONCOL, 147(1), 229-235. https://doi.org/10.1007/s11060-020-03419-6

Vancouver

Schroeder T, Bittrich P, Kuhne JF, Noebel C, Leischner H, Fiehler J et al. Mapping distribution of brain metastases: does the primary tumor matter? J NEURO-ONCOL. 2020 Mar;147(1):229-235. https://doi.org/10.1007/s11060-020-03419-6

Bibtex

@article{8cf4c2b15fd248b098247e73111f3bdd,
title = "Mapping distribution of brain metastases: does the primary tumor matter?",
abstract = "PURPOSE: Prior reports on the location and sizes of brain metastases almost entirely focus on patients with primary breast and pulmonary cancer. This is the first study comparing multiple other types of cancer that metastasize to the brain.METHODS: This monocentric retrospective study includes 369 untreated patients with 3313 intraaxial brain metastases. Following semi-manual segmentation of metastases on post-contrast T1WI, cumulative spatial probability distribution maps of brain metastases were created for the whole group and for all primary tumors. Furthermore, mixed effects logistic regression model analysis was performed to determine if the primary tumor, patient age, and patient sex influence lesion location.RESULTS: The cerebellum as location of brain metastases was proportionally overrepresented. Breast and pulmonary cancer caused higher number of brain metastases to what would normally be expected. Multivariate analyses revealed a significant accumulation of brain metastases from skin cancer in a frontal and from breast and gastrointestinal cancer in a cerebellar location.CONCLUSION: Distribution of brain metastases is very heterogeneous for the distinct primaries, possibly reflecting the diversity of mechanisms involved in brain metastases formation. In daily clinical practice distribution patters may be beneficial to predict the primary cancer site, if unknown.",
author = "T Schroeder and P Bittrich and Kuhne, {J F} and C Noebel and H Leischner and J Fiehler and J Schroeder and G Schoen and S Gelli{\ss}en",
year = "2020",
month = mar,
doi = "10.1007/s11060-020-03419-6",
language = "English",
volume = "147",
pages = "229--235",
journal = "J NEURO-ONCOL",
issn = "0167-594X",
publisher = "Kluwer Academic Publishers",
number = "1",

}

RIS

TY - JOUR

T1 - Mapping distribution of brain metastases: does the primary tumor matter?

AU - Schroeder, T

AU - Bittrich, P

AU - Kuhne, J F

AU - Noebel, C

AU - Leischner, H

AU - Fiehler, J

AU - Schroeder, J

AU - Schoen, G

AU - Gellißen, S

PY - 2020/3

Y1 - 2020/3

N2 - PURPOSE: Prior reports on the location and sizes of brain metastases almost entirely focus on patients with primary breast and pulmonary cancer. This is the first study comparing multiple other types of cancer that metastasize to the brain.METHODS: This monocentric retrospective study includes 369 untreated patients with 3313 intraaxial brain metastases. Following semi-manual segmentation of metastases on post-contrast T1WI, cumulative spatial probability distribution maps of brain metastases were created for the whole group and for all primary tumors. Furthermore, mixed effects logistic regression model analysis was performed to determine if the primary tumor, patient age, and patient sex influence lesion location.RESULTS: The cerebellum as location of brain metastases was proportionally overrepresented. Breast and pulmonary cancer caused higher number of brain metastases to what would normally be expected. Multivariate analyses revealed a significant accumulation of brain metastases from skin cancer in a frontal and from breast and gastrointestinal cancer in a cerebellar location.CONCLUSION: Distribution of brain metastases is very heterogeneous for the distinct primaries, possibly reflecting the diversity of mechanisms involved in brain metastases formation. In daily clinical practice distribution patters may be beneficial to predict the primary cancer site, if unknown.

AB - PURPOSE: Prior reports on the location and sizes of brain metastases almost entirely focus on patients with primary breast and pulmonary cancer. This is the first study comparing multiple other types of cancer that metastasize to the brain.METHODS: This monocentric retrospective study includes 369 untreated patients with 3313 intraaxial brain metastases. Following semi-manual segmentation of metastases on post-contrast T1WI, cumulative spatial probability distribution maps of brain metastases were created for the whole group and for all primary tumors. Furthermore, mixed effects logistic regression model analysis was performed to determine if the primary tumor, patient age, and patient sex influence lesion location.RESULTS: The cerebellum as location of brain metastases was proportionally overrepresented. Breast and pulmonary cancer caused higher number of brain metastases to what would normally be expected. Multivariate analyses revealed a significant accumulation of brain metastases from skin cancer in a frontal and from breast and gastrointestinal cancer in a cerebellar location.CONCLUSION: Distribution of brain metastases is very heterogeneous for the distinct primaries, possibly reflecting the diversity of mechanisms involved in brain metastases formation. In daily clinical practice distribution patters may be beneficial to predict the primary cancer site, if unknown.

U2 - 10.1007/s11060-020-03419-6

DO - 10.1007/s11060-020-03419-6

M3 - SCORING: Journal article

C2 - 32065345

VL - 147

SP - 229

EP - 235

JO - J NEURO-ONCOL

JF - J NEURO-ONCOL

SN - 0167-594X

IS - 1

ER -